Time optimal control studies on COVID-19 incorporating adverse events of the antiviral drugs
From MaRDI portal
Publication:2076182
DOI10.1515/cmb-2020-0125zbMath1482.92049arXiv2105.14433OpenAlexW3169683335MaRDI QIDQ2076182
Swapna Muthusamy, Carani B. Sanjeevi, Bishal Chhetri, V. S. Ananth, Vijay M. Bhagat, D. K. K. Vamsi
Publication date: 18 February 2022
Published in: Computational and Mathematical Biophysics (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/2105.14433
bang-bang controladverse eventsCOVID-19time optimal control problemfirst line drugssecond line drugs
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Optimal control of a delayed HIV infection model with immune response using an efficient numerical method
- A model of HIV-1 infection with two time delays: mathematical analysis and comparison with patient data
- Time-optimal control strategies in SIR epidemic models
- A micro-epidemic model for primary dengue infection
- Qualitative analysis and optimal control of a two-strain dengue model with its co-infections
- New class of Volterra integro-differential equations with fractal-fractional operators: existence, uniqueness and numerical scheme
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Mathematical modeling of Zika disease in pregnant women and newborns with microcephaly in Brazil
- Forecasting the daily and cumulative number of cases for the COVID-19 pandemic in India
- The Picard Algorithm for Ordinary Differential Equations in Coq
- Optimal control of SARS epidemics based on cybernetics
- Optimal control of an HIV immunology model
This page was built for publication: Time optimal control studies on COVID-19 incorporating adverse events of the antiviral drugs